GlassScriptPhysician profile
Peter Nelson Purcell
NPI 1932133170
$39,307.95
in general payments reported to CMS, 2019-2025
27 companies · $97.02 in 2025
The $97.02 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $296 · 2021: $4,434 · 2022: $8,567 · 2023: $10K · 2024: $15K · 2025: $97.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $25K · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $25,000.00 |
| Food and Beverage | $524.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $36,593.28 | 2021-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $912.34 | 2019-2023 | Xarelto |
| Medtronic, INC. | $535.37 | 2021-2022 | |
| Endologix LLC | $404.17 | 2022 | |
| Pfizer INC. | $184.23 | 2019-2021 | |
| Lemaitre Vascular, INC. | $93.58 | 2019-2025 | Artegraft Vascular Graft, Restoreflow |
| Boston Scientific Corporation | $58.40 | 2020-2024 | Varithena Administration Pack |
| Nuvasive, INC. | $52.45 | 2019 | |
| Bard Peripheral Vascular, INC. | $40.53 | 2023 | Venclose Maven Catheter |
| Ethicon US, LLC | $38.19 | 2020 | |
| Inari Medical, INC. | $38.17 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Integra Lifesciences Corporation | $35.89 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $34.08 | 2022-2023 | Pico 14, Pico 7, Renasys Touch |
| Dilon Technologies, INC. | $31.56 | 2025 | Hemoblast Bellows |
| Organogenesis INC. | $29.78 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $27.85 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $24.82 | 2021 | |
| Biocompatibles, INC. | $24.30 | 2019 | |
| Cordis US Corp. | $23.40 | 2025 | Mynx Control Venous |
| Acelrx Pharmaceuticals, INC. | $20.62 | 2019 | |
| Cashflow Solutions, LLC | $18.87 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Kci USA, INC. | $18.28 | 2021 | |
| Elutia, INC. | $17.68 | 2019 | |
| Melinta Therapeutics, LLC | $13.91 | 2019 | |
| Baudax Bio INC. | $13.79 | 2020 | |
| Medtronic Vascular, INC. | $12.50 | 2019 | |
| Venclose INC. | $9.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Purcell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.